CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention

GuidelineACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; hea

JOURNAL:Eur Heart J. Article Link

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski P, Voors AA, ESC Scientific Document Group. et al. Keywords: Arrhythmias; Cardiac resynchronization therapy; Co-morbidities; Diagnosis; Ejection fraction; Guidelines; Heart failure; Hospitalization; Mechanical circulatory support; Multidisciplinary management; Natriuretic peptides; Neuro-hormonal antagonists; Pharmacotherapy; Transplantation

Full Text PDF